Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis
Sipan Haikazian, David Chen‐Li, Danica E. Johnson, et al.
Psychiatry Research (2023) Vol. 329, pp. 115531-115531
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin
Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
Med (2024) Vol. 5, Iss. 3, pp. 190-200.e5
Closed Access | Times Cited: 28
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 1
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 215-234
Open Access | Times Cited: 6
Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review
Noah Chisamore, Danica E. Johnson, Margery J.Q. Chen, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 77-84
Closed Access | Times Cited: 6
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials
Shuping Fang, Xin Yang, Wei Zhang
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?
Daniel Villiger
International Review of Psychiatry (2024), pp. 1-10
Open Access | Times Cited: 5
The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy
Stephan Zipfel, Wolfgang Lutz, Silvia Schneider, et al.
Psychotherapy and Psychosomatics (2024) Vol. 93, Iss. 4, pp. 230-236
Closed Access | Times Cited: 4
A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?
Shaul Schreiber, Lee Keidan, Chaim G. Pick
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 208-208
Open Access
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access
The Role of Mitochondrial Dysfunction and Calcium Dysregulation in 2C-I and 25I-NBOMe-Induced Neurotoxicity
Eva Gil-Martins, Fernando Cagide, A. Borer, et al.
Chemico-Biological Interactions (2025), pp. 111425-111425
Closed Access
History of psychedelic drug science and molecular pharmacology
David E. Nichols, Charles D. Nichols
International review of neurobiology (2025)
Closed Access
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study
Josephine Yalovitser, jonah levine, Cole Zweber, et al.
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
The Effects of Psychedelic-Assisted Therapy on Illness and Death Anxiety: A Systematic Review and Meta-Analysis
Aron Amaev, Jianmeng Song, Yasaman Kambari, et al.
Journal of Psychiatric Research (2025)
Closed Access
Pharmacokinetics of Psilocybin: A Systematic Review
Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 411-411
Open Access
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
Noah Chisamore, Erica Kaczmarek, Zoe Doyle, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 829-829
Open Access | Times Cited: 2
Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial
Laetitia Vanderijst, Felix Hever, Anne Buot, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cultivating Pearls of Wisdom: Creating Protected Niche Spaces for Inner Transformations amidst the Metacrisis
Kira Jade Cooper, Don McIntyre, Dan McCarthy
Challenges (2024) Vol. 15, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia
Zohaib Nadeem, Stephen Parker, Hugh McGovern, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 10, pp. 904-913
Open Access | Times Cited: 1
Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression
Florian Freudenberg, Christine Reif-Leonhard, Andreas Reif
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 1
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder
Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, et al.
Psychedelic Medicine (2024)
Closed Access | Times Cited: 1
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 1
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial
Laetitia Vanderijst, Felix Hever, Anne Buot, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top